Wende Hutton is a seasoned investor and General Partner at Canaan Partners since 2004, specializing in Med tech, Digital Health, and Biopharmaceuticals. Notable board involvement includes companies such as Labrys Biologics, Dermira, Transcend Medical, and Chimerix. Prior experience includes roles as General Partner at Mayfield Fund from 1993 to 2001 and General Manager at GenPharm International for a brief period. Hutton also held various leadership positions at Nellcor from 1986 to 1990. Academic credentials include an AB in Human Biology from Stanford University and a degree from Harvard Business School.
Sign up to view 0 direct reports
Get started